![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstetrics and Gynecology 1993; 82: 78–83
- Dombrowski M P, Wolfe H M, Saleh A. The sonographically thick placenta: a predictor of increased perinatal morbidity and\rquote mortality. Ultrasound in Obstetrics and Gynecology 1992; 2: 241–242
- Harris R D, Cho C, Wells W A. Sonography of the placenta with emphasis on pathological correlation. Seminars in Ultrasound, CT, and MR 1996; 17: 66–89
- Jones K L. Deletion 13q syndrome. Smith's recognizable patterns of human malformation. 5th ed, K L Jones. WB Saunders, Philadelphia 1997; 60–61
- Katz V L, Chescheir N C, Cefalo R C. Unexplained elevations of maternal serum alpha-feto protein. Obstetrics and Gynecology Surgery 1990; 45: 719
- Metzenbauer M, Hafner E, Schuchter K, et al. First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population. Ultrasound in Obstetrics and Gynecology 2002; 19: 240–242
- Quélin C, Bendavid C, Dubourg C, et al. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress. European Journal of Medical Genetics 2009; 52: 41–46
- Raio L, Ghezzi F, Cromi A, et al. The thick heterogeneous (jellylike) placenta: a strong predictor of adverse pregnancy outcome. Prenatal Diagnosis 2004; 24: 182–188
- Reichler A, Hume R F, Jr, Drugan A, et al. Risk of anomalies as a function of level of elevated maternal serum alpha fetoprotein. American Journal of Obstetrics and Gynecology 1994; 171: 1052
- Stewart A K, Fonseca R. Review of molecular diagnostics in multiple myeloma. Expert Review of Molecular Diagnostics 2007; 7: 453–459